These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 1488864)

  • 1. [Cardiotoxicity of antineoplastic drugs].
    Drzewoski J; Kasznicki J
    Acta Haematol Pol; 1992; 23(2):79-86. PubMed ID: 1488864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of cardiotoxicity induced by anthracyclines.
    Elliott P
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer agents and cardiotoxicity.
    Ng R; Better N; Green MD
    Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthracycline cardiotoxicity.
    Menna P; Paz OG; Chello M; Covino E; Salvatorelli E; Minotti G
    Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S21-36. PubMed ID: 21635149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.
    Jones RL; Ewer MS
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1249-69. PubMed ID: 17020459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cardiac toxicity of cancer chemotherapy].
    Sequeira JF; Madruga IM; Ribeiro M; Duarte PC; Ferreira DC; Sarmento JL
    Acta Med Port; 1994 May; 7(5):311-8. PubMed ID: 8073908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiotoxicity of cancer therapy].
    Marek J; Linhart A; Rucklová Z; Haber J; Korínek J
    Vnitr Lek; 2011 May; 57(5):472-84. PubMed ID: 21695928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy.
    Ky B; Carver JR
    Heart Fail Clin; 2011 Jul; 7(3):323-31. PubMed ID: 21749884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline-induced cardiotoxicity in adult hematologic malignancies.
    Johnson SA
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S22-7. PubMed ID: 16781286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options].
    Urbanová D; Mladosievicová B
    Vnitr Lek; 2007 Jun; 53(6):669-77. PubMed ID: 17702127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity.
    Menna P; Minotti G; Salvatorelli E
    Cell Biol Toxicol; 2007 Jan; 23(1):49-62. PubMed ID: 17031515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity and pulmonary toxicity of chemotherapy].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):934-41. PubMed ID: 2188614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy and cardiotoxicity].
    Brestescher C; Pautier P; Farge D
    Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):443-7. PubMed ID: 8669796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges of evaluating the cardiac effects of anticancer agents.
    Bates SE; Rosing DR; Fojo T; Piekarz RL
    Clin Cancer Res; 2006 Jul; 12(13):3871-4. PubMed ID: 16818679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiotoxicity of drugs used in oncology].
    Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
    Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.
    Adão R; de Keulenaer G; Leite-Moreira A; Brás-Silva C
    Rev Port Cardiol; 2013 May; 32(5):395-409. PubMed ID: 23623503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.
    Minotti G; Menna P; Salvatorelli E; Cairo G; Gianni L
    Pharmacol Rev; 2004 Jun; 56(2):185-229. PubMed ID: 15169927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of oncological treatment in children.
    Kucharska W; Negrusz-Kawecka M; Gromkowska M
    Adv Clin Exp Med; 2012; 21(3):281-8. PubMed ID: 23214190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.